thiophenes has been researched along with Lymphocytopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marsolais, D; Oldstone, MB; Rosen, H; Walsh, KB; Welch, MJ | 1 |
| Igarashi, S; Lai, LW; Lien, YH; Yong, KC | 1 |
2 other study(ies) available for thiophenes and Lymphocytopenia
| Article | Year |
|---|---|
Treatment with a sphingosine analog does not alter the outcome of a persistent virus infection.
Topics: Animals; Antiviral Agents; beta-Alanine; Fingolimod Hydrochloride; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Lymphopenia; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Propylene Glycols; Sphingosine; Thiophenes; Treatment Outcome | 2010 |
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Movement; Chemokines; Fluorescent Antibody Technique; Kidney; Kidney Pelvis; Lymphopenia; Male; Mice; Oxadiazoles; Receptors, Lysosphingolipid; Reperfusion Injury; Thiophenes | 2007 |